Literature DB >> 19861875

Epstein syndrome with rapid progression to end stage renal disease.

Esam Alhindawi1, Samah Al-Jbour.   

Abstract

The association of haematological abnormalities and hereditary nephritis is rare; it is mainly included in a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly, Fechtner, Sebastian, Epstein and Alport syndrome with macro thrombocytopenia. We are presenting a missed case of a boy who presented with epistaxis and his diagnostic work up revealed macrothrombocytopenia, sensorineural hearing loss and chronic nephropathy which constitute the Epstein syndrome, with rapid deterioration of kidney function.

Entities:  

Mesh:

Year:  2009        PMID: 19861875

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  5 in total

1.  Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?

Authors:  Jeffrey B Kopp
Journal:  Kidney Int       Date:  2010-07       Impact factor: 10.612

2.  Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.

Authors:  Sima Babayeva; Michelle Miller; Yulia Zilber; Reyhan El Kares; Chantale Bernard; Martin Bitzan; Paul Goodyer; Elena Torban
Journal:  Pediatr Nephrol       Date:  2011-03-06       Impact factor: 3.714

3.  Genetic contribution and associated pathophysiology in end-stage renal disease.

Authors:  Suraksha Agrawal; Ss Agarwal; Sita Naik
Journal:  Appl Clin Genet       Date:  2010-08-05

4.  The May-Hegglin anomaly in a kidney transplant recipient.

Authors:  Fabio Fabbian; Franco Ricci; Alfredo De Giorgi; Silvia Forcellini; Giovanni Scanelli
Journal:  NDT Plus       Date:  2010-02-28

5.  MYH9-related disorders display heterogeneous kidney involvement and outcome.

Authors:  Nahid Tabibzadeh; Dominique Fleury; Delphine Labatut; Frank Bridoux; Arnaud Lionet; Noémie Jourde-Chiche; François Vrtovsnik; Nicole Schlegel; Philippe Vanhille
Journal:  Clin Kidney J       Date:  2018-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.